Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector–triggered immune responses in vitro and in vivo

Adenovirus (Ad) vectors are widely used in human clinical trials. However, at higher dosages, Ad vector–triggered innate toxicities remain a major obstacle to many applications. Ad interactions with the complement system significantly contribute to innate immune responses in several models of Ad-med...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Seregin, Sergey S., Aldhamen, Yasser A., Appledorn, Daniel M., Hartman, Zachary C., Schuldt, Nathaniel J., Scott, Jeannine, Godbehere, Sarah, Jiang, Haixiang, Frank, Michael M., Amalfitano, Andrea
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Hematology 2010
Θέματα:
Gene Therapy
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2947391/
https://ncbi.nlm.nih.gov/pubmed/20511542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-03-276949
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια